Jay Matushak - Oct 4, 2023 Form 4 Insider Report for Bright Health Group Inc. (BHG)

Role
Chief Financial Officer
Signature
/s/ Eric Halverson for Jay Matushak, Attorney-in-Fact
Stock symbol
BHG
Transactions as of
Oct 4, 2023
Transactions value $
-$497
Form type
4
Date filed
10/6/2023, 06:50 PM
Previous filing
Jun 30, 2023
Next filing
Mar 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHG Common Stock Options Exercise +264 +9.84% 2.95K Oct 4, 2023 Direct F1
transaction BHG Common Stock Sale -$497 -87 -2.95% $5.71 2.86K Oct 5, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHG Restricted Stock Units Options Exercise $0 -264 -50.09% $0.00 263 Oct 4, 2023 Common Stock 264 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F3 These shares were sold in multiple transactions, all at $5.71 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each such transaction.
F4 These restricted stock units vest over three years as follows: (a) one-third of the original grant amount vested on October 4, 2022, (b) one-third of the original grant amount vested on October 4, 2023, (c) and one-third of the original grant amount vests on October 4, 2024.